ACM
QNRX

AIGH Capital Management’s Quoin Pharmaceuticals QNRX Stock Holding History

AIGH Capital Management’s Portfolio QNRX Stock Details QNRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$337K Buy
51,000
+1,677
+3% +$15.2K 0.05% 42
2025
Q4 		$712K Buy
+49,323
New +$671K 0.17% 32

Other funds holding QNRX

IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
DIG
Dauntless Investment Group Etna, New Hampshire $151M AUM 76.14% 1-Year Est. Return
SC
SummitTX Capital Fort Worth, Texas $3.2B AUM 41.22% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
CC
Centiva Capital New York $13.6B AUM 20% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return

AIGH Capital Management's QNRX Position: Q1 2026 in Review

AIGH Capital Management increased its Quoin Pharmaceuticals (QNRX) stake by 3.4% in Q1 2026, buying an estimated $15.2K and bringing the position to 51,000 shares worth $337K. The position accounts for 0.05% of the portfolio, ranked #42.

AIGH Capital Management first reported a position in QNRX in Q4 2025 and has held it in 2 quarters since. The position peaked at $712K in Q4 2025. 22 funds tracked by Wall St. Rank hold QNRX as of Q1 2026.

  • AIGH Capital Management held 51,000 shares of Quoin Pharmaceuticals worth $337K as of Q1 2026.
  • AIGH Capital Management bought 1,677 Quoin Pharmaceuticals shares in Q1 2026, an estimated $15.2K.
  • Quoin Pharmaceuticals made up 0.05% of AIGH Capital Management's portfolio in Q1 2026, its #42 holding.
  • AIGH Capital Management first reported a position in Quoin Pharmaceuticals in Q4 2025 and has held it in 2 quarters since.
  • AIGH Capital Management's Quoin Pharmaceuticals position peaked at $712K in Q4 2025.
  • 22 funds tracked by Wall St. Rank held Quoin Pharmaceuticals as of Q1 2026.

Based on AIGH Capital Management's 13F filing for Q1 2026, filed 30 Apr 2026.